1. Home
  2. Labeler Index
  3. Maia Pharmaceuticals, Inc.
  4. 70511-113
  5. NDC Package Code: 70511-113-10 Levothyroxine Sodium

NDC Package 70511-113-10 Levothyroxine Sodium

Levothyroxine Sodium Anhydrous Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70511-113-10
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-USE
Product Code:
70511-113
Proprietary Name:
Levothyroxine Sodium
Non-Proprietary Name:
Levothyroxine Sodium Anhydrous
Substance Name:
Levothyroxine Sodium Anhydrous
Usage Information:
Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as certain types of goiters, thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.
11-Digit NDC Billing Format:
70511011310
NDC to RxNorm Crosswalk:
  • RxCUI: 1115267 - levothyroxine sodium 100 MCG Injection
  • RxCUI: 1115267 - levothyroxine sodium 0.1 MG Injection
  • RxCUI: 1115269 - levothyroxine sodium 200 MCG Injection
  • RxCUI: 1115269 - levothyroxine sodium 0.2 MG Injection
  • RxCUI: 966219 - levothyroxine sodium 500 MCG Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Maia Pharmaceuticals, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • LEVOTHYROXINE SODIUM ANHYDROUS 500 ug/5mL
    • Pharmacologic Class(es):
  • Thyroxine - [CS]
  • l-Thyroxine - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA208749
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-27-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70511-113-10?

    The NDC Packaged Code 70511-113-10 is assigned to a package of 1 vial, single-use in 1 carton / 5 ml in 1 vial, single-use of Levothyroxine Sodium, a human prescription drug labeled by Maia Pharmaceuticals, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 70511-113 included in the NDC Directory?

    Yes, Levothyroxine Sodium with product code 70511-113 is active and included in the NDC Directory. The product was first marketed by Maia Pharmaceuticals, Inc. on December 27, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70511-113-10?

    The 11-digit format is 70511011310. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270511-113-105-4-270511-0113-10